CN112136894A - Nutritional dietary supplement food beneficial to cardiovascular health and preparation method and application thereof - Google Patents
Nutritional dietary supplement food beneficial to cardiovascular health and preparation method and application thereof Download PDFInfo
- Publication number
- CN112136894A CN112136894A CN202010861536.8A CN202010861536A CN112136894A CN 112136894 A CN112136894 A CN 112136894A CN 202010861536 A CN202010861536 A CN 202010861536A CN 112136894 A CN112136894 A CN 112136894A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- dietary supplement
- raw materials
- cardiovascular health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 57
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 51
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 45
- 230000036996 cardiovascular health Effects 0.000 title claims abstract description 40
- 230000009286 beneficial effect Effects 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 73
- 239000000284 extract Substances 0.000 claims abstract description 19
- 239000000126 substance Substances 0.000 claims abstract description 15
- 230000006860 carbon metabolism Effects 0.000 claims abstract description 14
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 13
- 240000003768 Solanum lycopersicum Species 0.000 claims abstract description 13
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 12
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract description 11
- 235000013339 cereals Nutrition 0.000 claims abstract description 11
- 235000013336 milk Nutrition 0.000 claims abstract description 11
- 239000008267 milk Substances 0.000 claims abstract description 11
- 210000004080 milk Anatomy 0.000 claims abstract description 11
- 235000012055 fruits and vegetables Nutrition 0.000 claims abstract description 10
- 239000003381 stabilizer Substances 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 230000008569 process Effects 0.000 claims abstract description 5
- 241000894006 Bacteria Species 0.000 claims abstract description 4
- 239000004310 lactic acid Substances 0.000 claims abstract description 4
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims description 31
- 150000001875 compounds Chemical class 0.000 claims description 25
- 235000013373 food additive Nutrition 0.000 claims description 23
- 239000002778 food additive Substances 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 12
- 235000013312 flour Nutrition 0.000 claims description 11
- 235000018102 proteins Nutrition 0.000 claims description 11
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 9
- 239000003086 colorant Substances 0.000 claims description 9
- 235000009508 confectionery Nutrition 0.000 claims description 9
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
- 235000014121 butter Nutrition 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 5
- 240000000249 Morus alba Species 0.000 claims description 5
- 235000008708 Morus alba Nutrition 0.000 claims description 5
- 229920001100 Polydextrose Polymers 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 5
- 229940029339 inulin Drugs 0.000 claims description 5
- 235000013856 polydextrose Nutrition 0.000 claims description 5
- 239000001259 polydextrose Substances 0.000 claims description 5
- 229940035035 polydextrose Drugs 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 229940054810 white kidney bean extract Drugs 0.000 claims description 5
- 230000008901 benefit Effects 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 3
- 240000005979 Hordeum vulgare Species 0.000 claims description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 3
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003451 Vitamin B1 Natural products 0.000 claims description 3
- 229930003779 Vitamin B12 Natural products 0.000 claims description 3
- 229930003471 Vitamin B2 Natural products 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 229960000367 inositol Drugs 0.000 claims description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 3
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 3
- 235000019175 phylloquinone Nutrition 0.000 claims description 3
- 239000011772 phylloquinone Substances 0.000 claims description 3
- 229960001898 phytomenadione Drugs 0.000 claims description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 3
- 229960002477 riboflavin Drugs 0.000 claims description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 229960003080 taurine Drugs 0.000 claims description 3
- 229960003495 thiamine Drugs 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000010374 vitamin B1 Nutrition 0.000 claims description 3
- 239000011691 vitamin B1 Substances 0.000 claims description 3
- 235000019163 vitamin B12 Nutrition 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 235000019164 vitamin B2 Nutrition 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 235000019158 vitamin B6 Nutrition 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 229940011671 vitamin b6 Drugs 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- SERLAGPUMNYUCK-YJOKQAJESA-N 6-O-alpha-D-glucopyranosyl-D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-YJOKQAJESA-N 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 235000021537 Beetroot Nutrition 0.000 claims description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- 240000006162 Chenopodium quinoa Species 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- 244000163122 Curcuma domestica Species 0.000 claims description 2
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 244000130270 Fagopyrum tataricum Species 0.000 claims description 2
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 2
- 241000186315 Lactobacillus paracasei N1115 Species 0.000 claims description 2
- 229920000161 Locust bean gum Polymers 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 2
- 102000014171 Milk Proteins Human genes 0.000 claims description 2
- 108010011756 Milk Proteins Proteins 0.000 claims description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 244000151637 Sambucus canadensis Species 0.000 claims description 2
- 235000018735 Sambucus canadensis Nutrition 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 229940023476 agar Drugs 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 2
- 235000013734 beta-carotene Nutrition 0.000 claims description 2
- 239000011648 beta-carotene Substances 0.000 claims description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 2
- 125000001409 beta-carotene group Chemical group 0.000 claims description 2
- 229960002747 betacarotene Drugs 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 235000007123 blue elder Nutrition 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 235000003373 curcuma longa Nutrition 0.000 claims description 2
- 235000007124 elderberry Nutrition 0.000 claims description 2
- 235000008995 european elder Nutrition 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 229940014259 gelatin Drugs 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 235000010420 locust bean gum Nutrition 0.000 claims description 2
- 239000000711 locust bean gum Substances 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 235000021239 milk protein Nutrition 0.000 claims description 2
- 229940038580 oat bran Drugs 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 235000008476 powdered milk Nutrition 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 239000011669 selenium Substances 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 235000020183 skimmed milk Nutrition 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 235000013976 turmeric Nutrition 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- 235000008939 whole milk Nutrition 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims 3
- 241001134770 Bifidobacterium animalis Species 0.000 claims 1
- 229940118852 bifidobacterium animalis Drugs 0.000 claims 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 8
- 235000012054 meals Nutrition 0.000 abstract description 7
- 230000035764 nutrition Effects 0.000 abstract description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 4
- 239000011707 mineral Substances 0.000 abstract description 4
- 235000005911 diet Nutrition 0.000 abstract description 3
- 230000000378 dietary effect Effects 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 2
- 229940088594 vitamin Drugs 0.000 abstract description 2
- 229930003231 vitamin Natural products 0.000 abstract description 2
- 235000013343 vitamin Nutrition 0.000 abstract description 2
- 239000011782 vitamin Substances 0.000 abstract description 2
- 238000007580 dry-mixing Methods 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 26
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 235000012000 cholesterol Nutrition 0.000 description 12
- 230000009102 absorption Effects 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 150000001720 carbohydrates Chemical class 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 108010028554 LDL Cholesterol Proteins 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 3
- 239000004380 Cholic acid Substances 0.000 description 3
- 108010023302 HDL Cholesterol Proteins 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 3
- 235000019416 cholic acid Nutrition 0.000 description 3
- 229960002471 cholic acid Drugs 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000009200 high fat diet Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 108010004103 Chylomicrons Proteins 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 239000003392 amylase inhibitor Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000021258 carbohydrate absorption Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 125000001895 carotenoid group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/133—Fruit or vegetables
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
Abstract
The invention discloses a nutritional dietary supplement food beneficial to cardiovascular health, and a preparation method and application thereof, and belongs to the field of food processing. The nutritional dietary supplement food provided by the invention takes milk powder as a main carrier, is added with cereal powder, protein powder, fruit and vegetable powder, multiple vitamins, mineral substances, lactic acid bacteria, a stabilizer and the like, is particularly added with carbon metabolism retardant, phytosterol, EPA and/or DHA, tomato extract, dietary fiber and other substances, and is prepared by a dry mixing method to obtain the dietary nutritional supplement food beneficial to cardiovascular health; the food is beneficial to cardiovascular health, has rich nutrition and good taste, and can be used as meal replacement; the preparation method has simple process and easy control, and the prepared product has good stability. The nutritional dietary supplement food of the present invention is suitable for consumption by consumers who are interested in preventing cardiovascular disease.
Description
Technical Field
The invention belongs to the field of food processing, and relates to a nutritional dietary supplement food, in particular to a nutritional dietary supplement food beneficial to cardiovascular health, and a preparation method and application thereof.
Background
Since the 70 s of the last century, with the rapid improvement of the living standard of people and the rapid change of life style, particularly eating habits, the incidence of cardiovascular diseases such as coronary heart disease and the like is gradually increased, the suffering age is about to be younger, and the cardiovascular diseases become the first health killer which troubles people in China.
At present, in functional cardiovascular health-care food aiming at cardiovascular diseases on the market, Chinese medicinal component extracts and some pure blood fat reducing medicines are added, the product forms are capsules, tablets, granules and the like, the physiological state and the food requirements of people are not considered, and the food does not have the function of meal replacement; products with partial meal replacement function, such as black sesame paste, walnut powder and the like, cannot meet the nutritional and health-care requirements of people in multiple dimensions. Therefore, the development of a nutritional dietary supplement food which is beneficial to cardiovascular health, rich in nutrition and good in taste and can be used as a meal replacement is urgently needed.
Disclosure of Invention
The invention aims to provide a nutritional dietary supplement food beneficial to cardiovascular health, so as to solve the problem that the functional cardiovascular health food in the prior art can not satisfy the nutritional, health-care and food requirements of people in multiple dimensions;
another object of the present invention is to provide a method for preparing the above nutritional dietary supplement food beneficial to cardiovascular health;
it is a further object of the present invention to provide the use of the above nutritional dietary supplement food for cardiovascular health benefits.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
a nutritional dietary supplement food beneficial to cardiovascular health comprises the following raw materials of active ingredients in parts by weight: 650-750 parts of milk powder, 150-230 parts of cereal powder, 10-70 parts of protein powder, 1-30 parts of dietary fiber, 2-50 parts of sweet substance, 2-20 parts of stabilizer, 1-40 parts of phytosterol and 2-15 parts of compound food additive I;
the compound food additive comprises the following raw materials: 0.003 to 0.017 portion of vitamin A, 0.00001 to 0.000125 portion of vitamin D, 0.076 to 0.31 portion of vitamin E, 0.3 to 2.25 portions of vitamin C, 0 to 0.00044 portion of vitamin K1, 0 to 0.022 portion of vitamin B1, 0 to 0.022 portion of vitamin B2, 0 to 0.022 portion of vitamin B6, 0 to 0.000066 portions of vitamin B12, 0 to 0.33 portion of nicotinic acid, 0 to 0.006 portion of folic acid, 0 to 0.08 portion of pantothenic acid, 0 to 0.000076 portions of biotin, 0 to 3.4 portions of choline, 0 to 2.5 portions of inositol, 0 to 0.5 portion of taurine, 0 to 0.4 portion of L-carnitine and 0 to 2 portions of nucleotide.
As a limitation of the present invention:
the reducing material for preparing the effective components comprises the following components in parts by weight: at least one of EPA, DHA, carbon metabolism retarder and tomato extract, wherein the carbon metabolism retarder comprises the following raw materials: white kidney bean extract and mulberry leaf extract.
As a further limitation of the invention:
the active ingredients of the medicine composition comprise the following raw materials in parts by weight: 0.1-20 parts of EPA and/or DHA, 0.1-10 parts of carbon metabolism retarder and 0.1-5 parts of tomato extract.
As another limitation of the present invention:
the raw materials for preparing the effective components of the compound food additive also comprise 0.03-50 parts of compound food additive No. 2 by weight, and the raw materials of the compound food additive No. 2 comprise: 0 to 6.00 parts of potassium element, 0 to 0.0075 parts of copper element, 0 to 1.10 parts of magnesium element, 0 to 0.20 parts of iron element, 0.03 to 0.06 parts of zinc element, 0 to 0.043 parts of manganese element, 0 to 7.20 parts of calcium element, 0 to 4.20 parts of phosphorus element, 0 to 0.001 parts of iodine element, 0 to 4.50 parts of chlorine element, 0 to 0.00028 parts of selenium element, 0 to 0.00021 parts of chromium element and 0 to 0.00038 parts of molybdenum element.
As still further limitations of the present invention:
the raw materials for preparing the effective components of the compound also comprise 0.001-1 part of colorant and 1-10 parts of fruit and vegetable powder by weight, wherein the colorant is beta-carotene; the fruit and vegetable powder is any one of red beet concentrated juice powder, carrot powder, blueberry powder, elderberry powder and turmeric.
As a further limitation of the invention:
the raw materials for preparing the active ingredients of the edible oil comprise, by weight, 0.3-3 parts of sodium citrate and/or sodium tripolyphosphate, 0.2-3 parts of edible essence and 0.01-10 parts of sodium alginate.
As a further limitation of the invention:
the active ingredients of the lactobacillus preparation comprise 1-30 parts by weight of lactobacillus, wherein the lactobacillus comprises lactobacillus paracasei N1115 and animal bifidobacteria.
As a third limitation of the present invention:
the cereal powder comprises any one of rice flour, tartary buckwheat powder, oat powder, coix seed powder, highland barley powder, oat bran powder, corn flour and quinoa powder; the milk powder comprises at least one of whole milk powder and skim milk powder; the protein powder comprises at least one of whey protein powder and milk protein powder; the dietary fiber comprises at least one of inulin, polydextrose and resistant dextrin; the sweet substance is any one of xylitol, isomaltitol, crystalline fructose and solid glucose syrup; the stabilizer comprises any one of xanthan gum, starch, pectin, arabic gum, guar gum, locust bean gum, agar, sodium alginate, carrageenan and gelatin.
The invention also provides a preparation method of the nutritional dietary supplement food beneficial to cardiovascular health, and the raw materials for preparing the effective components of the nutritional dietary supplement food comprise: 650-750 parts of milk powder, 150-230 parts of cereal powder, 10-70 parts of protein powder, 1-30 parts of dietary fiber, 2-50 parts of sweet substances, 2-20 parts of stabilizing agents, 1-40 parts of phytosterol, 2-15 parts of compound food additives (I), 0.1-20 parts of EPA and/or DHA, 0.1-10 parts of carbon metabolism retardant, 0.1-5 parts of tomato extract, 0.03-50 parts of compound food additives (II), 0.001-1 part of colorant, 1-10 parts of fruit and vegetable powder, 0.3-3 parts of sodium citrate and/or sodium tripolyphosphate, 0.2-3 parts of edible essence and 0.01-10 parts of butter powder, wherein the preparation method comprises the following steps in sequence:
1) screening and weighing of raw materials: detecting that the total number of the bacterial colonies of all the raw materials is within 5000CFU/g and the fineness of the raw materials is not higher than 10 meshes, and then respectively weighing the raw materials;
2) primary premixing: sequentially screening protein powder, butter powder, dietary fiber, sweet substances, compound food additive I, compound food additive II, carbon metabolism retarder, phytosterol, EPA and/or DHA, tomato extract, stabilizer, colorant, fruit and vegetable powder and milk powder with a 10-40-mesh sieve, and mixing for 5-10 minutes to obtain a mixed material A;
3) secondary premixing: sequentially sieving the grain powder, the sodium citrate and/or the sodium tripolyphosphate and the edible essence by a sieve with 10-40 meshes, and mixing for 5-10 minutes to obtain a mixed material B;
4) total mixing: and mixing the mixed material A and the mixed material B for 5-10 minutes to prepare the nutritional dietary supplement food beneficial to cardiovascular health. The invention also provides a preparation method of the nutritional dietary supplement food beneficial to cardiovascular health, which is characterized in that 1 weight part of the nutritional dietary supplement food beneficial to cardiovascular health is added into 2-10 weight parts of water, and the obtained product is brewed into a beverage with the viscosity of 8000-90000 cP and is used for consumers who intentionally prevent cardiovascular diseases to drink.
Due to the adoption of the technical scheme, compared with the prior art, the invention has the technical progress that:
in the added carbon metabolism blockers, namely the white kidney bean extract and the mulberry leaf extract, the alpha-amylase inhibitor in the white kidney bean extract can inhibit the activity of saliva and amylopsin in the gastrointestinal tract, effectively blocks the decomposition of starch in high-starch foods, further blocks the heat generated by human bodies absorbing starch foods and inhibits the absorption of carbohydrates; DNJ in the mulberry leaf extract is a natural active substance alpha-glucosidase inhibitor, and is structurally an analogue of monosaccharide, the affinity of the alpha-glucosidase inhibitor and the glucosidase is obviously greater than that of disaccharide or polysaccharide, and binding sites of the alpha-glucosidase are in reversible competition with carbohydrate molecules on brush edges of small intestinal epithelial cells, so that the polysaccharide and oligosaccharide are delayed to be converted into absorbable monosaccharide, the increase of postprandial blood sugar is effectively controlled, and the blood sugar is stably and slowly maintained at a certain level; the white kidney bean extract and the mulberry leaf extract act together to reduce the conversion of carbohydrate to fat in vivo;
the added phytosterol is an active ingredient widely existing in plants, and the chemical structure of the phytosterol is similar to that of cholesterol, so that the phytosterol can replace the position of the cholesterol in human intestinal chylomicron in the human digestive process, reduce the absorption of the cholesterol in the human intestinal tract and promote the discharge of the cholesterol in blood;
the EPA added in the invention helps to reduce the contents of cholesterol and triglyceride and promote the metabolism of saturated fatty acid in vivo, thereby playing the roles of reducing the blood viscosity, promoting the blood circulation, preventing the deposition of fat on the blood vessel wall, preventing the formation and the development of atherosclerosis and preventing cardiovascular diseases such as cerebral thrombosis, cerebral hemorrhage, hypertension and the like; DHA can reduce triglyceride and cholesterol in blood and prevent thrombosis;
the added tomato extract is a carotenoid, has strong oxidation resistance and can inhibit platelet aggregation, and the lycopene in the tomato extract can prevent the oxidation of low-density lipoprotein in blood, so that the formation of arteriosclerosis is inhibited, and cardiovascular and cerebrovascular diseases such as hypertension, hyperlipidemia, coronary heart disease and the like are improved;
the added dietary fiber is a component which is not digested by digestive enzymes of a human body in food, has excellent health care function, and is known as important nutrients except carbohydrates, protein, fat, mineral substances and vitamins in recent years, including inulin, resistant dextrin and polydextrose. Wherein inulin has the advantages of reducing serum Total Cholesterol (TC) and low density lipoprotein cholesterol (LDL-C), increasing high density lipoprotein/low density lipoprotein ratio, improving blood lipid condition, reducing blood sugar, and promoting mineral absorption; the resistant dextrin helps to delay and inhibit the digestion and absorption of the small intestine to saccharides, improves the sensitivity of peripheral tissues to insulin, reduces the demand of insulin, helps to maintain normal and healthy blood sugar level and insulin level, and can change the secretion of digestive tract hormones and the activity of digestive enzymes in the intestinal tract, inhibit the digestion and absorption of saccharides and further play a role in reducing blood sugar; polydextrose can form a film in the small intestine, wrap part of food fat, effectively limit the absorption of fat in the digestive tract, promote the excretion of lipoid compound, increase satiety, reduce food intake, so as to regulate blood fat and reduce fat accumulation, and can adsorb organic molecules of bile acid, cholesterol mutagen and the like, inhibit the rise of Total Cholesterol (TC) concentration, reduce the synthesis and absorption of cholic acid and salts, reduce the levels of human plasma and liver cholesterol, prevent and treat coronary arteriosclerosis, cholelithiasis and prevent cardiovascular and cerebrovascular diseases;
in conclusion, the invention takes the milk powder as a carrier, mainly adds the cereal powder, the protein powder, the multivitamins, the dietary fibers (inulin and/or resistant dextrin and/or polydextrose), the EPA and/or DHA and the phytosterol, and selectively adds the carbon metabolism retardant, the tomato extract, the lactic acid bacteria and various mineral substances at the same time, and each substance respectively exerts the advantages thereof and plays the combined action in various aspects of blocking carbohydrate absorption, reducing blood sugar, promoting lipoid discharge, inhibiting cholesterol synthesis and absorption, promoting cholesterol discharge, reducing free radicals in blood and the like, thereby improving the cardiovascular health of the human body;
the invention combines the functional function, the edible state and the nutritional requirement of human body of the product at the same time, develop a dietary nutrition supplement food beneficial to cardiovascular health and its preparation method, the food is beneficial to cardiovascular health, nutritious, and the food granularity is smaller, the viscosity is suitable after being mixed with water, the mouthfeel is good, can be regarded as the meal to replace meal; the preparation method of the food has simple process and easy control, and the prepared product has good stability.
The present invention is useful for providing a nutritional dietary supplement food beneficial to cardiovascular health, which is suitable for consumption by consumers who are interested in preventing cardiovascular disease.
Detailed Description
Example 1A nutritional dietary supplement food product for cardiovascular health and a method of making the same
The embodiment is a nutritional dietary supplement food beneficial to cardiovascular health and a preparation method thereof, and the nutritional dietary supplement food is sequentially prepared according to the following steps:
1) screening and weighing of raw materials: after detecting that the total number of the bacterial colonies of all the raw materials is within 5000CFU/g and the fineness of the raw materials is not higher than 10 meshes, respectively weighing the following raw materials according to the proportion of a formula:
the compound food additive comprises:
composition of matter | Addition amount (kg) |
Vitamin A | 0.0065 |
Vitamin D | 0.00003875 |
Vitamin E | 0.1345 |
Vitamin C | 0.7875 |
Vitamin K1 | 0.00011 |
Vitamin B1 | 0.0055 |
Vitamin B2 | 0.0055 |
Vitamin B6 | 0.0055 |
Vitamin B12 | 0.0000165 |
Nicotinic acid | 0.0825 |
Folic acid | 0.0015 |
Pantothenic acid | 0.02 |
Biotin | 0.000019 |
Choline | 0.85 |
Inositol | 0.625 |
Taurine | 0.125 |
L-carnitine | 0.1 |
Nucleotide, its preparation and use | 0.5 |
Lactose | 2.00081575 |
② the compound food additive comprises:
2) primary premixing: sequentially screening protein powder, butter powder, dietary fiber, sweet substances, compound food additive I, compound food additive II, carbon metabolism retarder, phytosterol, EPA and/or DHA, tomato extract, stabilizer, colorant, fruit and vegetable powder and milk powder with a 10-40-mesh sieve, and mixing for 5-10 minutes to obtain a mixed material A;
3) secondary premixing: sequentially sieving the grain powder, the sodium citrate and/or the sodium tripolyphosphate and the edible essence by a sieve with 10-40 meshes, and mixing for 5-10 minutes to obtain a mixed material B;
4) total mixing: and mixing the mixed material A and the mixed material B for 5-10 minutes to obtain a finished product.
The nutritional dietary supplement food beneficial to cardiovascular health prepared by the embodiment is simple in preparation process and easy to control, and the prepared product has good stability, is rich in nutrition and good in taste and can be used as a dietary meal replacement.
Examples 2-11 methods of making nutritional dietary supplement foods that are beneficial for cardiovascular health
Examples 2-11 are processes for the preparation of a nutritional dietary supplement food product for cardiovascular health, respectively, wherein the preparation steps are similar to example 1, except that: the relevant parameters are different, and are specifically shown in the following table:
examples 2-11 formulation tables
The compound food additive of No. I in the examples 2 to 11 comprises:
the second compound food additive in the examples 2 to 11 comprises:
EXAMPLES 2-11 preparation procedure parameter Table
Example 12 nutritional test results for nutritional dietary supplement foods with beneficial cardiovascular health
The nutrient composition table of the nutritional dietary supplement foods beneficial to cardiovascular health prepared in examples 1-11 is shown in the following table, and it can be seen that the nutritional dietary supplement food provided by the present invention is rich in nutrition and can meet the nutritional needs of consumers.
Example 13 Effect test of nutritional dietary supplement food for cardiovascular health
Randomly dividing 30 adult mice into 3 groups, wherein each group comprises 10 mice, namely a normal group, a control group and an experimental group, and independently feeding the 3 mice, wherein the normal group is fed with common feed and water; control group was fed high fat diet (containing 75% normal diet, 10% lard, 0.3% cholic acid and 15% egg yolk powder); experimental groups were fed a high fat diet (containing 75% of the nutritional dietary supplement prepared in example 1, 10% lard, 0.3% cholic acid and 15% egg yolk powder); the feeding time is 150 days continuously, the feeding is carried out for 12 hours after 50 days, 100 days and 150 days, blood is taken from a venous plexus after the eyeball is punctured, 0.4-0.5 mL is obtained, 3000g is centrifuged for 10min, serum is taken, and TC, TG, LDL-C and HDL-C levels are detected by a full-automatic biochemical tester, and the results are shown in the following table:
compared with the normal group, the serum levels of TC, TG and LDL-C of the mice of the control group and the experimental group are obviously increased (P <0.05), and the HDL-C is obviously reduced (P < 0.05); compared with a control group, the average levels of TC, TG and LDL-C in the serum of the mice in an experimental group are obviously reduced (P is less than 0.05), and the level of HDL-C is obviously increased (P is less than 0.05), which indicates that the eating of the nutritional dietary supplement food beneficial to cardiovascular health can effectively reduce the contents of cholesterol, triglyceride and low-density lipoprotein, improve the content of high-density lipoprotein and is beneficial to the protection and improvement of cardiovascular diseases.
Although the present invention has been described in detail with reference to the above embodiments, it will be apparent to those skilled in the art that modifications may be made to the embodiments described above, or equivalents may be substituted for elements thereof. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (10)
1. A nutritional dietary supplement food beneficial to cardiovascular health is characterized in that the raw materials for preparing the effective components of the nutritional supplement food comprise the following components in parts by weight: 650-750 parts of milk powder, 150-230 parts of cereal powder, 10-70 parts of protein powder, 1-30 parts of dietary fiber, 2-50 parts of sweet substance, 2-20 parts of stabilizer, 1-40 parts of phytosterol and 2-15 parts of compound food additive I;
the compound food additive comprises the following raw materials: 0.003 to 0.017 portion of vitamin A, 0.00001 to 0.000125 portion of vitamin D, 0.076 to 0.31 portion of vitamin E, 0.3 to 2.25 portions of vitamin C, 0 to 0.00044 portion of vitamin K1, 0 to 0.022 portion of vitamin B1, 0 to 0.022 portion of vitamin B2, 0 to 0.022 portion of vitamin B6, 0 to 0.000066 portions of vitamin B12, 0 to 0.33 portion of nicotinic acid, 0 to 0.006 portion of folic acid, 0 to 0.08 portion of pantothenic acid, 0 to 0.000076 portions of biotin, 0 to 3.4 portions of choline, 0 to 2.5 portions of inositol, 0 to 0.5 portion of taurine, 0 to 0.4 portion of L-carnitine and 0 to 2 portions of nucleotide.
2. The cardiovascular health beneficial nutritional dietary supplement food product of claim 1, wherein the raw materials from which its active ingredients are made further comprise: at least one of EPA, DHA, carbon metabolism retarder and tomato extract, wherein the carbon metabolism retarder comprises the following raw materials: white kidney bean extract and mulberry leaf extract.
3. The nutritional dietary supplement food product for cardiovascular health according to claim 2, wherein the raw materials for its active ingredients comprise, in parts by weight: 0.1-20 parts of EPA and/or DHA, 0.1-10 parts of carbon metabolism retarder and 0.1-5 parts of tomato extract.
4. A nutritional dietary supplement food beneficial to cardiovascular health according to any one of claims 1-3, characterized in that the raw materials of the active ingredients of the nutritional supplement food further comprise 0.03-50 parts of compound No. 2 food additive by weight, and the raw materials of the compound No. 2 food additive comprise: 0 to 6.00 parts of potassium element, 0 to 0.0075 parts of copper element, 0 to 1.10 parts of magnesium element, 0 to 0.20 parts of iron element, 0.03 to 0.06 parts of zinc element, 0 to 0.043 parts of manganese element, 0 to 7.20 parts of calcium element, 0 to 4.20 parts of phosphorus element, 0 to 0.001 parts of iodine element, 0 to 4.50 parts of chlorine element, 0 to 0.00028 parts of selenium element, 0 to 0.00021 parts of chromium element and 0 to 0.00038 parts of molybdenum element.
5. The nutritional dietary supplement food beneficial to cardiovascular health as claimed in claim 4, wherein the raw materials for preparing the effective ingredients further comprise 0.001-1 part by weight of a colorant and 1-10 parts by weight of fruit and vegetable powder, wherein the colorant is beta-carotene; the fruit and vegetable powder is any one of red beet concentrated juice powder, carrot powder, blueberry powder, elderberry powder and turmeric.
6. The nutritional dietary supplement food beneficial to cardiovascular health as claimed in claim 5, wherein the raw materials for preparing the effective ingredients further comprise, by weight, 0.3-3 parts of sodium citrate and/or sodium tripolyphosphate, 0.2-3 parts of edible essence, and 0.01-10 parts of butter powder.
7. The nutritional dietary supplement food beneficial to cardiovascular health according to claim 6, characterized in that the raw materials for preparing the effective ingredients thereof further comprise 1-30 parts by weight of lactic acid bacteria, wherein the lactic acid bacteria comprise lactobacillus paracasei N1115 and bifidobacterium animalis.
8. A nutritional dietary supplement food product according to any one of claims 1 to 3 and 5 to 7, wherein said cereal flour comprises any one of rice flour, tartary buckwheat flour, oat flour, barley flour, highland barley flour, oat bran flour, corn flour, quinoa flour; the milk powder comprises at least one of whole milk powder and skim milk powder; the protein powder comprises at least one of whey protein powder and milk protein powder; the dietary fiber comprises at least one of inulin, polydextrose and resistant dextrin; the sweet substance is any one of xylitol, isomaltitol, crystalline fructose and solid glucose syrup; the stabilizer comprises any one of xanthan gum, starch, pectin, arabic gum, guar gum, locust bean gum, agar, sodium alginate, carrageenan and gelatin.
9. A process for the preparation of a nutritional dietary supplement food product for cardiovascular health benefits according to any one of claims 1 to 8 wherein the active ingredients comprise, in parts by weight: 650-750 parts of milk powder, 150-230 parts of cereal powder, 10-70 parts of protein powder, 1-30 parts of dietary fiber, 2-50 parts of sweet substances, 2-20 parts of stabilizing agents, 1-40 parts of phytosterol, 2-15 parts of compound food additives, 0.1-20 parts of EPA and/or DHA, 0.1-10 parts of carbon metabolism retardant, 0.1-5 parts of tomato extract, 0.03-50 parts of compound food additives, 0.001-1 part of colorant, 1-10 parts of fruit and vegetable powder, 0.3-3 parts of sodium citrate and/or sodium tripolyphosphate, 0.2-3 parts of edible essence and 0.01-10 parts of butter powder, wherein the preparation method comprises the following steps in sequence:
1) screening and weighing of raw materials: detecting that the total number of the bacterial colonies of all the raw materials is within 5000CFU/g and the fineness of the raw materials is not higher than 10 meshes, and then respectively weighing the raw materials;
2) primary premixing: sequentially screening protein powder, butter powder, dietary fiber, sweet substances, compound food additive I, compound food additive II, carbon metabolism retarder, phytosterol, EPA and/or DHA, tomato extract, stabilizer, colorant, fruit and vegetable powder and milk powder with a 10-40-mesh sieve, and mixing for 5-10 minutes to obtain a mixed material A;
3) secondary premixing: sequentially sieving the grain powder, the sodium citrate and/or the sodium tripolyphosphate and the edible essence by a sieve with 10-40 meshes, and mixing for 5-10 minutes to obtain a mixed material B;
4) total mixing: and mixing the mixed material A and the mixed material B for 5-10 minutes to prepare the nutritional dietary supplement food beneficial to cardiovascular health.
10. The use of the cardiovascular health beneficial nutritional dietary supplement of any of claims 1-8, wherein 1 part by weight of said cardiovascular health beneficial nutritional dietary supplement is added to 2-10 parts by weight of water and reconstituted to a beverage with a viscosity of 8000-90000 cP for consumption by a consumer intended to prevent cardiovascular disease.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010861536.8A CN112136894A (en) | 2020-08-25 | 2020-08-25 | Nutritional dietary supplement food beneficial to cardiovascular health and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010861536.8A CN112136894A (en) | 2020-08-25 | 2020-08-25 | Nutritional dietary supplement food beneficial to cardiovascular health and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112136894A true CN112136894A (en) | 2020-12-29 |
Family
ID=73889048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010861536.8A Withdrawn CN112136894A (en) | 2020-08-25 | 2020-08-25 | Nutritional dietary supplement food beneficial to cardiovascular health and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112136894A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115053959A (en) * | 2022-07-05 | 2022-09-16 | 三奇生物医药(山东)有限公司 | Special diet food based on dyslipidemia patients and preparation method thereof |
CN116420875A (en) * | 2023-02-06 | 2023-07-14 | 黑龙江飞鹤乳业有限公司 | Nutritional composition for assisting blood lipid regulation and cardiovascular and cerebrovascular health |
-
2020
- 2020-08-25 CN CN202010861536.8A patent/CN112136894A/en not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115053959A (en) * | 2022-07-05 | 2022-09-16 | 三奇生物医药(山东)有限公司 | Special diet food based on dyslipidemia patients and preparation method thereof |
CN116420875A (en) * | 2023-02-06 | 2023-07-14 | 黑龙江飞鹤乳业有限公司 | Nutritional composition for assisting blood lipid regulation and cardiovascular and cerebrovascular health |
CN116420875B (en) * | 2023-02-06 | 2024-03-15 | 黑龙江飞鹤乳业有限公司 | Nutritional composition for assisting blood lipid regulation and cardiovascular and cerebrovascular health |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11723943B2 (en) | Therapeutic use of chardonnay seed products | |
CN102687750B (en) | Weight losing and meal replacement protein type solid beverage | |
DE60122570T2 (en) | FOOD COMPOSITION FOR IMMUNE DISEASE | |
CN103653170B (en) | Stachyose probiotics solid beverage | |
CN104544432A (en) | Samara oil compound protein solid beverage and method for preparing same | |
US20040253227A1 (en) | Perioperative multivitamin protein beverage and additive for use in preparing an individual for fast surgical recovery | |
CN110800904A (en) | Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof | |
CN112136894A (en) | Nutritional dietary supplement food beneficial to cardiovascular health and preparation method and application thereof | |
CN101095520A (en) | Foodstuff having lipid-lowering and slimming functions | |
CN110810468B (en) | Ketogenic cookies and preparation method thereof | |
CN115066188A (en) | Composition comprising a metal oxide and a metal oxide | |
KR100787554B1 (en) | Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood | |
US10448661B2 (en) | Dry food composition | |
KR20220058176A (en) | Prebiotics composition for improving intestinal microflora | |
CN111165816A (en) | Weight-losing meal replacement powder for relaxing bowels and preparation method thereof | |
US20220369677A1 (en) | Cereal Compositions Containing Human Milk Oligosaccharides | |
CN116058499B (en) | Mediterranean diet fruit and vegetable fat-reducing meal replacement powder and preparation method and application thereof | |
CN115886171B (en) | Composite solid beverage and preparation method thereof | |
CN112493475B (en) | Salty meal replacement powder for regulating intestines and stomach and preparation method thereof | |
TWM536946U (en) | Food structure containing probiotic of arabinose | |
CN112056353A (en) | Camel milk dietary fiber meal replacement biscuit and preparation method thereof | |
RU2556909C1 (en) | Method for production of beverage concentrate based on biologically active food additive (versions), such instant beverage concentrate formula, method for preparation and method for application of beverage produced from such concentrate | |
CN117898335A (en) | Formula of flavored solid beverage | |
CN101623015A (en) | Novel nutrient bakery food capable of replacing dinner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20201229 |
|
WW01 | Invention patent application withdrawn after publication |